Precigen
PGEN
#4973
Rank
โ‚ฌ1.73 B
Marketcap
4,87ย โ‚ฌ
Share price
2.50%
Change (1 day)
262.07%
Change (1 year)

Revenue for Precigen (PGEN)

Revenue in 2026 (TTM): โ‚ฌ27.19 Million

According to Precigen's latest financial reports the company's current revenue (TTM ) is โ‚ฌ27.77 Million. In 2025 the company made a revenue of โ‚ฌ8.24 Million an increase over the revenue in the year 2024 that were of โ‚ฌ3.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Precigen from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ27.19 M229.85%
2025 โ‚ฌ8.24 M118.56%
2024 โ‚ฌ3.77 M-33.02%
2023 โ‚ฌ5.63 M-77.55%
2022 โ‚ฌ25.08 M-49.16%
2021 โ‚ฌ49.34 M-41.18%
2020 โ‚ฌ83.88 M14.49%
2019 โ‚ฌ73.26 M-47.8%
2018 โ‚ฌ0.14 B-27.16%
2017 โ‚ฌ0.19 B6.17%
2016 โ‚ฌ0.18 B14.32%
2015 โ‚ฌ0.15 B168.46%
2014 โ‚ฌ59.14 M247.75%
2013 โ‚ฌ17 M61.56%
2012 โ‚ฌ10.52 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚ฌ0.12 M-99.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ19.19 M-30.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚ฌ0.52 B 1,787.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚ฌ0.59 B 2,034.56% Jersey